News about Global Pharma

SCHOTT Pharma Announces USD 371 Mn Investment in North Carolina for New Manufacturing Facility

The upcoming facility will be the first of its kind in the US, dedicated to manufacturing prefillable polymer syringes essential for the deep-cold storage and transportation of mRNA medications.

Global Pharma | 19/03/2024 | By Abha |  774

Philippine Government Collaborates with FDA to Propel Pharmaceutical Economic Zones

This initiative aims to strengthen the country's drug and medical device manufacturing sectors through the establishment of pharmaceutical economic zones.

Global Pharma | 19/03/2024 | By Abha |  781

UP Govt Announces to Produce and Export in Pharma Sector Soon

Chief Minister Yogi Adityanath has announced that Uttar Pradesh will become a producer and exporter of pharmaceutical products soon.

Global Pharma | 19/03/2024 | By Manvi |  865

Eris Lifesciences Announces Acquisition of Biocon Biologics

Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.

Global Pharma | 19/03/2024 | By Manvi |  667

Sanofi India Forges Exclusive Distribution Partnership with Emcure Pharma

Sanofi India has signed an exclusive distribution and promotion agreement with Emcure Pharma for Sanofi’s cardiovascular products in India.

Global Pharma | 19/03/2024 | By Manvi |  1253

Sulzer to Deliver Technology and Key Equipment to India?s First Bioplastics Plant

Sulzer to deliver technology and key equipment to India’s first bioplastics plant to boost sustainable manufacturing in the region

Global Pharma | 18/03/2024 | By Manvi |  516

Neupulse Secures Funding to Advance World's First Wearable Device to Tackle Tourettes Syndrome

Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialization.

Global Pharma | 18/03/2024 | By Manvi |  684

Noramco Launches Noramco Group to Strengthen North American Pharmaceutical Supply Chain

This initiative integrates subsidiaries Purisys, Noramco, and recently acquired drug product CDMO, Halo Pharma, to enhance the region's clinical and commercial API and drug product supply chain.

Global Pharma | 18/03/2024 | By Abha |  590

Aptar Expands North American Capacity to Meet Growing Demand for Drug Delivery Systems

This investment aims to address the increasing demand for proprietary drug delivery systems in both prescription and consumer healthcare markets across North America, benefiting local customers.

Global Pharma | 18/03/2024 | By Abha |  539

BeiGene Receives FDA Approval for TEVIMBRA

BeiGene announced that the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA ® (tislelizumab) as a treatment for adult patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) who have previously received unresectable or metastatic esophageal squamous cell carcinoma (ESCC).

Global Pharma | 16/03/2024 | By Manvi |  739